Skip to main content
Caplight Logo









Evolutia Bio

Evolutia Bio

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://evolutiabio.com/

Last Round

Private Placement

Jul 18, 2024

Total Funding Raised

$31.89M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Evolutia Bio is a biotechnology company that develops proprietary biomanufacturing solutions, including custom enzymes, engineered strains, and processes for ingredient and industrial partners.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

biomanufacturingsynthetic biologyprecision fermentationcustom enzyme developmentengineered strainsbiocatalysissynbiodesign-build-test-learnDBTLbioprocess engineeringscale-upcomputational biologyprotein engineeringindustrial biotechbio-based ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evolutia Bio Comparables

Compare Evolutia Bio with similar companies based on industry and business-model similarity.

Evolutia Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Conagen
85%
Lygos
82%
Manus Bio
81%

Evolutia Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJul 18, 2024
Convertible DebtOct 10, 2023
Follow-on OfferingFeb 19, 2021
Follow-on OfferingOct 29, 2020

Evolutia Bio Investors

Notable investors and investment history

Evolutia Bio investors
InvestorRounds
Canaccord GenuityFollow-on Offering
ATB Capital MarketsFollow-on Offering
BMO Capital MarketsFollow-on Offering
Eight CapitalFollow-on Offering

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Grew 17% QoQ, from 18 to 21 employees.

  • Feb 21, 2025

    Grew 19% QoQ, from 21 to 25 employees.

Evolutia Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evolutia Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evolutia Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range23
Year Founded2019
Last FundingJul 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.